GlassScriptPhysician profile
Sarah E Buckingham
NPI 1447549639
$11,449.35
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $113 · 2021: $323 · 2022: $307 · 2023: $4,490 · 2024: $6,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,975 · Food and Beverage: $462 · Travel and Lodging: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,975.00 |
| Food and Beverage | $461.57 |
| Travel and Lodging | $133.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $10,186.41 | 2023-2024 | Nourianz |
| Sk Life Science, INC. | $383.11 | 2022-2024 | Xcopri |
| Medtronic, INC. | $166.11 | 2021-2023 | Percept PC Brainsense |
| Abbvie INC. | $161.72 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $118.05 | 2021 | |
| Medtronic USA, INC. | $113.47 | 2020 | |
| Amgen INC. | $99.18 | 2022 | |
| Biogen, INC. | $86.26 | 2021 | |
| Adamas Pharmaceuticals, INC. | $70.40 | 2019 | |
| Abbott Laboratories | $64.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Buckingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.